Germany
Japan
United Kingdom
China
Primary Antibodies
View as table Download
Rabbit Polyclonal FOXP3 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Rabbit polyclonal FOXP3 antibody was raised against a 15 amino acid peptide near the carboxy terminus of human FOXP3. The immunogen is located within the last 50 amino acids of FOXP3. |
Rabbit anti-STAT1 (Phospho-Tyr701) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT1 around the phosphorylation site of tyrosine 701 (T-G-YP-I-K). |
| Modifications | Phospho-specific |
Rabbit anti-NF-kB p105/p50 (Phospho-Ser337) polyclonal antibody (Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanNF-κB p105/p50 around the phosphorylation site of serine 337 (R-K-SP-D-L). |
| Modifications | Phospho-specific |
Rabbit Polyclonal PPARGC1A Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | PPARGC1A antibody was raised against a 19 amino acid peptide near the carboxy terminus of human PPARGC1A. The immunogen is located within the last 50 amino acids of PPARGC1A. |
Rabbit polyclonal IRF-3 (Ser385) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human IRF-3 around the phosphorylation site of serine 385 (G-A-SP-S-L). |
| Modifications | Phospho-specific |
Rabbit Polyclonal Anti-KV11.1 (HERG) (extracellular)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide AFLLKETEEGPPATEC corresponding to residues 430-445 of human KV11.1 (HERG). Extracellular, between S1 and S2 domains. |
Rabbit anti-STAT3 (Phospho-Tyr705) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT3 around the phosphorylation site of tyrosine 705 (A-P-YP-L-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal Nuclear Receptor NR4A1 (Ab-351) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Nuclear Receptor NR4A1 around the phosphorylation site of serine 351 (L-P-SP-K-P). |
Rabbit anti-PARP1 Polyclonal Antibody
| Applications | ICC/IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide of human PARP1 |
Rabbit anti-TFAM Polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human TFAM |
Rabbit polyclonal GR (Ab-211) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human GR around the phosphorylation site of serine 211 (N-E-S-P-W). |
Rabbit Polyclonal IRF7 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | IRF7 antibody was raised against a peptide corresponding to 14 amino acids near the carboxy terminus of human IRF7. The immunogen is located within amino acids 420 - 470 of IRF7. |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Anti-SOX2 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to C terminal 250 amino acids of human SRY (sex determining region Y)-box 2 |
Anti-SMAD7 rabbit polyclonal antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 370-383 amino acids of Human SMAD family member 7 |
Anti-FOXO1 (Phospho-Ser256) Rabbit Polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide sequence around phosphorylation site of serine 256 (A-A-S(p)-M-D) derived from Human FKHR. |
| Modifications | Phospho-specific |
Anti-SPDEF Rabbit Polyclonal Antibody
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 129-332 amino acids of human SAM pointed domain containing ets transcription factor |
Rabbit Polyclonal Anti-MYCN Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human MYCN |
USD 379.00
In Stock
USD 159.00
In Stock
USD 379.00
In Stock
Active filters
Reactivities
- Rat
Applications
- IHC
Families
- Transcription Factors
Citations
- Yes
Filter by
Category
Target Symbol
- ZEB1 (5)
- CTNNB1 (4)
- PRRX1 (4)
- SNAI2 (4)
- EPAS1 (3)
- NR4A3 (3)
- PARP1 (3)
- RELA (3)
- SOX17 (3)
- STAT3 (3)
- ARNT (2)
- ARNTL (2)
- CDX2 (2)
- EGR2 (2)
- ESR1 (2)
- ETS2 (2)
- EZH2 (2)
- FOSL1 (2)
- FOXP3 (2)
- GATA4 (2)
- HOXD10 (2)
- KEAP1 (2)
- PAX5 (2)
- PDX1 (2)
- PRKAR1A (2)
- SATB1 (2)
- SEC14L2 (2)
- SMURF2 (2)
- SQSTM1 (2)
- TLE1 (2)
- TP63 (2)
- WWTR1 (2)
- ZEB2 (2)
- CCNE1 (1)
- FOXO1 (1)
- FOXP1 (1)
- GAS7 (1)
- GATA3 (1)
- HIF1A (1)
- HOXC8 (1)
- IRF3 (1)
- IRF7 (1)
- KCNH2 (1)
- MYCN (1)
- NFKB1 (1)
- NONO (1)
- NR3C1 (1)
- NR4A1 (1)
- POU5F1 (1)
- PPARGC1A (1)
- RNF2 (1)
- RUNX3 (1)
- SMAD7 (1)
- SOD2 (1)
- SOX2 (1)
- SOX9 (1)
- SPDEF (1)
- STAT1 (1)
- TFAM (1)
- VHL (1)
Antibody Hosts
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (21)
- Prostate cancer (10)
- Wnt signaling pathway (9)
- Adherens junction (8)
- Adipocytokine signaling pathway (8)
- Chemokine signaling pathway (8)
- Pancreatic cancer (8)
- Acute myeloid leukemia (7)
- Renal cell carcinoma (7)
- Toll-like receptor signaling pathway (7)
- Apoptosis (6)
- Cytosolic DNA-sensing pathway (6)
- RIG-I-like receptor signaling pathway (6)
- MAPK signaling pathway (5)
- Small cell lung cancer (5)
- Ubiquitin mediated proteolysis (5)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (4)
- B cell receptor signaling pathway (4)
- Basal cell carcinoma (4)
- Chronic myeloid leukemia (4)
- Colorectal cancer (4)
- Endometrial cancer (4)
- Epithelial cell signaling in Helicobacter pylori infection (4)
- Focal adhesion (4)
- Insulin signaling pathway (4)
- Jak-STAT signaling pathway (4)
- Leukocyte transendothelial migration (4)
- Melanogenesis (4)
- NOD-like receptor signaling pathway (4)
- Neurotrophin signaling pathway (4)
- Pathogenic Escherichia coli infection (4)
- T cell receptor signaling pathway (4)
- Thyroid cancer (4)
- Tight junction (4)
- Base excision repair (3)
- Huntington's disease (3)
- TGF-beta signaling pathway (3)
- Allograft rejection (2)
- Antigen processing and presentation (2)
- Autoimmune thyroid disease (2)
- Cell adhesion molecules (CAMs) (2)
- Circadian rhythm - mammal (2)
- Dorso-ventral axis formation (2)
- Endocytosis (2)
- Graft-versus-host disease (2)
- Maturity onset diabetes of the young (2)
- Type I diabetes mellitus (2)
- Type II diabetes mellitus (2)
- Viral myocarditis (2)
- Cell cycle (1)
- Metabolic pathways (1)
- Neuroactive ligand-receptor interaction (1)
- Oocyte meiosis (1)
- mTOR signaling pathway (1)
- p53 signaling pathway (1)